Depreciation of Armata Pharmaceuticals, Inc. from 31 Mar 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Armata Pharmaceuticals, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2013 to 30 Sep 2025.
  • Armata Pharmaceuticals, Inc. Depreciation for the quarter ending 30 Sep 2025 was $400,000, a 33% increase year-over-year.
  • Armata Pharmaceuticals, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $1,500,000, a 15% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Depreciation for 2024 was $1,300,000, a 30% increase from 2023.
  • Armata Pharmaceuticals, Inc. annual Depreciation for 2023 was $1,000,000, a 11% increase from 2022.
  • Armata Pharmaceuticals, Inc. annual Depreciation for 2022 was $900,000, a 23% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Armata Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,500,000 $400,000 +$100,000 +33% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $300,000 $0 0% 01 Jun 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $1,400,000 $400,000 +$100,000 +33% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $1,300,000 $400,000 $0 0% 01 Oct 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
Q3 2024 $1,300,000 $300,000 +$100,000 +50% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $1,200,000 $300,000 +$100,000 +50% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $1,100,000 $300,000 +$100,000 +50% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $1,000,000 $400,000 +$126,000 +46% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q3 2023 $874,000 $200,000 $0 0% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $874,000 $200,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $874,000 $200,000 -$26,000 -12% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $900,000 $274,000 -$14,000 -4.9% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $914,000 $200,000 -$100,000 -33% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $1,014,000 $200,000 -$100,000 -33% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $1,114,000 $226,000 -$55,000 -20% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $1,169,000 $288,000 +$69,000 +32% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $1,100,000 $300,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $1,100,000 $300,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $1,100,000 $281,000 -$14,000 -4.7% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $1,114,000 $219,000 -$49,000 -18% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $1,163,000 $300,000 -$100,000 -25% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $1,263,000 $300,000 -$35,000 -10% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $1,298,000 $295,000 -$53,000 -15% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $1,351,000 $268,000 -$257,000 -49% 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 $1,608,000 $400,000 +$64,000 +19% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $1,544,000 $335,000 -$66,000 -16% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $1,610,000 $348,000 +$259,000 +291% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $1,351,000 $525,000 01 Oct 2018 31 Dec 2018 10-K 19 Mar 2020 2019 FY
Q3 2018 $336,000 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $401,000 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $89,000 +$4,000 +4.7% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q1 2017 $85,000 +$12,000 +16% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $73,000 +$15,000 +26% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q1 2015 $58,000 +$40,000 +222% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q1 2014 $18,000 -$3,000 -14% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 $21,000 01 Jan 2013 31 Mar 2013 10-Q/A 15 Apr 2015 2014 Q1

Armata Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,300,000 +$300,000 +30% 01 Jan 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
2023 $1,000,000 +$100,000 +11% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
2022 $900,000 -$269,000 -23% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $1,169,000 +$55,000 +4.9% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $1,114,000 -$237,000 -18% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $1,351,000 $0 0% 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
2018 $1,351,000 +$1,008,000 +294% 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2020 2019 FY
2017 $343,000 +$5,000 +1.5% 01 Jan 2017 31 Dec 2017 10-K 25 Mar 2019 2018 FY
2016 $338,000 +$39,000 +13% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2018 2017 FY
2015 $299,000 +$172,000 +135% 01 Jan 2015 31 Dec 2015 10-K 27 Mar 2017 2016 FY
2014 $127,000 +$45,000 +55% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $82,000 01 Jan 2013 31 Dec 2013 10-K 15 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.